Targeted therapy with tyrosine kinase inhibitors has been shown to reduce tumor volumes and prolong the survival of patients with metastatic renal cell carcinoma. Tyrosine kinase inhibitors, particularly sunitinib, have recently been used in neoadjuvant and presurgical settings. Axitinib is a…
Source:Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
Saturday, November 23, 2013
Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment